Why DNTH? Dianthus Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
DNTH
$87.42-0.38 (-0.43%)
Market ClosedLast close May 1
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases.